• Explore /
  • Poster
  • / The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for patients with advanced renal cell carcinoma receiving first-line sunitinib.

The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for patients with advanced renal cell carcinoma receiving first-line sunitinib.

Abstract Poster

Authors

null

Maristella Bianconi

Scuola di Specializzazione in Oncologia Medica, Università Politecnica delle Marche, Ancona, Italy

Maristella Bianconi , Mario Scartozzi , Luca Faloppi , Riccardo Giampieri , Elena Maccaroni , Alessandro Bittoni , Michela Del Prete , Cristian Loretelli , Laura Belvederesi , Alessandro Conti , Daniele Minardi , Luciano Burattini , Rodolfo Montironi , Stefano Cascinu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session E: Renal Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Citation

J Clin Oncol 30, 2012 (suppl 5; abstr 380)

DOI

10.1200/jco.2012.30.5_suppl.380

Abstract #

380

Poster Bd #

C3

Abstract Disclosures

Similar Posters

First Author: Maristella Bianconi

First Author: Chris Labaki

First Author: Daniel M. Geynisman

First Author: Neil J. Shah